CNBTD
ABBV icon

Citizens National Bank Trust Department’s AbbVie ABBV Stock Holding History

Citizens National Bank Trust Department’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
41,402
-96
-0.2% -$20.7K 1.53% 16
2026
Q1 		$9.03M Buy
41,498
+116
+0.3% +$25.7K 1.5% 18
2025
Q4 		$9.46M Buy
41,382
+321
+0.8% +$73.1K 1.63% 14
2025
Q3 		$9.51M Buy
41,061
+515
+1% +$105K 1.7% 13
2025
Q2 		$7.53M Buy
40,546
+1,122
+3% +$209K 1.5% 21
2025
Q1 		$8.26M Buy
39,424
+551
+1% +$107K 1.76% 15
2024
Q4 		$6.91M Sell
38,873
-70
-0.2% -$12.9K 1.46% 21
2024
Q3 		$7.69M Buy
38,943
+185
+0.5% +$34.5K 1.62% 19
2024
Q2 		$6.65M Buy
38,758
+610
+2% +$101K 1.48% 20
2024
Q1 		$6.95M Sell
38,148
-635
-2% -$109K 1.61% 19
2023
Q4 		$6.01M Sell
38,783
-220
-0.6% -$32.1K 1.52% 21
2023
Q3 		$5.81M Sell
39,003
-762
-2% -$112K 1.6% 21
2023
Q2 		$5.36M Sell
39,765
-2,340
-6% -$343K 1.42% 22
2023
Q1 		$6.71M Sell
42,105
-885
-2% -$135K 1.86% 10
2022
Q4 		$6.95M Sell
42,990
-156
-0.4% -$23.9K 1.96% 10
2022
Q3 		$5.79M Sell
43,146
-35
-0.1% -$5.02K 1.79% 11
2022
Q2 		$6.61M Buy
43,181
+12,825
+42% +$1.96M 1.9% 10
2022
Q1 		$4.46M Sell
30,356
-330
-1% -$47.9K 1.79% 16
2021
Q4 		$4.16M Sell
30,686
-12,814
-29% -$1.51M 1.58% 19
2021
Q3 		$4.69M Sell
43,500
-730
-2% -$83.4K 1.33% 20
2021
Q2 		$4.98M Buy
44,230
+1,530
+4% +$172K 1.43% 18
2021
Q1 		$4.62M Buy
42,700
+2,595
+6% +$278K 1.4% 22
2020
Q4 		$4.3M Buy
40,105
+100
+0.2% +$9.61K 1.41% 21
2020
Q3 		$3.5M Hold
40,005
– – 1.37% 22
2020
Q2 		$3.93M Buy
40,005
+2,150
+6% +$189K 1.68% 16
2020
Q1 		$2.88M Buy
+37,855
New +$3.22M 1.54% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citizens National Bank Trust Department's ABBV Position: Q2 2026 in Review

Citizens National Bank Trust Department reduced its AbbVie (ABBV) stake by 0.23% in Q2 2026, selling an estimated $20.7K and leaving 41,402 shares worth $10.4M. The position accounts for 1.53% of the portfolio, ranked #16.

Citizens National Bank Trust Department first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Citizens National Bank Trust Department held 41,402 shares of AbbVie worth $10.4M as of Q2 2026.
  • Citizens National Bank Trust Department sold 96 AbbVie shares in Q2 2026, an estimated $20.7K.
  • AbbVie made up 1.53% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #16 holding.
  • Citizens National Bank Trust Department first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.